Statistics
Publications
5
Citations
389
H-Index
5
Active since
2020
Mason R. Firpo is an author at Loyola University Chicago specializing in antiviral therapeutics, antiviral therapy, and drug discovery.
Publications per year
2020–2023
5
5
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones et al. · Science · 2021 · 255 citations · Full text
Mason R. Firpo, Natalie J. LoMascolo, Marine J. Petit et al. · PLoS Pathogens · 2023 · 13 citations · Full text
1–5 of 5